Mandeep Othee, MD
Pain Medicine · Odessa, TXNPI 1295850436
Payments from drug & device makers
Across 47 payments — averaging $89.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Si-bone, Inc.$2K
- AbbVie$223
- Vertex$95
- Scilex Pharmaceuticals Inc.$67
- Johnson & Johnson$44
- plus $153 from 8 others
What the payments were for
- Travel & lodging$3,37881%
- Food & beverage$81019%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 7 | $2,032 |
| Si-bone, Inc. | 8 | $1,572 |
| AbbVie(2 entities) | 13 | $223 |
| Vertex | 4 | $95 |
| Scilex Pharmaceuticals Inc. | 4 | $67 |
| Johnson & Johnson | 2 | $44 |
| Lilly USA, LLC | 2 | $33 |
| Globus Medical | 1 | $28 |
| Averitas Pharma Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $18 |
| IBSA Pharma Inc. | 1 | $15 |
| Merck | 1 | $12 |
| Pacira Therapeutics, Inc. | 1 | $12 |
| Novartis | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPINEJACK$1,921
- IFUSE IMPLANT SYSTEM$1,456
- MULTIGEN 2$111
How this compares
$4,188 in reported general payments places this provider in the 55th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 663 | $13,181 |
| MovantikNaloxegol Oxalate | 12 | $4,474 |
| Diclofenac Sodium | 55 | $2,098 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 68 | $1,517 |
| Gabapentin | 135 | $1,500 |
| Tizanidine Hcl | 147 | $960 |
| Morphine Sulfate ErMorphine Sulfate | 45 | $950 |
| Tramadol Hcl | 82 | $810 |
| Pregabalin | 25 | $612 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 37 | $570 |
| Cyclobenzaprine Hcl | 52 | $450 |
| Methocarbamol | 47 | $420 |
| Methylprednisolone | 38 | $312 |
| Baclofen | 20 | $251 |
| Hydromorphone Hcl | 12 | $92 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Odessa
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Muhammad ZulqarnainDallas$556K
- Daniel PakHouston$460K
- Marvin ChangSugar Land$306K
- David LeimanHouston$281K
- Candice BurnetteSugar Land$265K
- Ellen LinSan Antonio$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.